Tuning the activity of platinum(IV) anticancer complexes through asymmetric acylation

Journal of Medicinal Chemistry

Volumn 55, Issue 17, 2012, Pages 7571-7582

  Chin, Chee Fei ^a   Tian, Quan ^a   Setyawati, Magdiel Inggrid ^a   Fang, Wanru ^a   Tan, Emelyn Sue Qing ^a   Leong, David Tai ^a   Ang, Wee Han ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CARBOXYLIC ACID; CISPLATIN; OXOPLATIN; PLATINUM COMPLEX;

ACYLATION; ARTICLE; DRUG EFFICACY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOPHILICITY; OVARY CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; X RAY DIFFRACTION;

ACYLATION; ANTINEOPLASTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLOGRAPHY, X-RAY; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; PLATINUM; SOLUBILITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 84866340471     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm300580y     Document Type: Article

References (59)

1. Kelland, L. The Resurgence of Platinum-Based Cancer Chemotherapy Nature Rev. Cancer 2007, 7, 573-584 (Pubitemid 47106628)
2. Horwich, A.; Shipley, J.; Huddart, R. Testicular Germ-Cell Cancer Lancet 2006, 367, 754-765 (Pubitemid 43326294)
3. Wang, D.; Lippard, S. J. Cellular Processing of Platinum Anticancer Drugs Nature Rev. Drug Discovery 2005, 4, 307-320 (Pubitemid 41130944)
4. Jamieson, E. R.; Lippard, S. J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts Chem. Rev. 1999, 99, 2467-2498
5. Fuertes, M. A.; Alonso, C.; Pérez, J. M. Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance Chem. Rev. 2003, 103, 645-662
6. Chin, C. F.; Wong, D. Y. Q.; Jothibasu, R.; Ang, W. H. Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity Curr. Top. Med. Chem. 2011, 11, 2602-2612
7. Sternberg, C. N.; Whelan, P.; Hetherington, J.; Paluchowska, B.; Slee, P. H.; Vekemans, K.; Van Erps, P.; Theodore, C.; Koriakine, O.; Oliver, T.; Lebwohl, D.; Debois, M.; Zurlo, A.; Collette, L. Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer Oncology 2005, 68, 2-9 (Pubitemid 40675002)
8. Choy, H.; Park, C.; Yao, M. Current Status and Future Prospects for Satraplatin, an Oral Platinum Analogue Clin. Cancer Res. 2008, 14, 1633-1638 (Pubitemid 351469447)
9. Kostrhunova, H.; Vrana, O.; Suchankova, T.; Gibson, D.; Kasparkova, J.; Brabec, V. Different Features of the DNA Binding Mode of Antitumor cis -Amminedichlorido(cyclohexylamine)platinum(II) (JM118) and Cisplatin in Vitro Chem. Res. Toxicol. 2010, 23, 1833-1842
10. Kostrhunova, H.; Kasparkova, J.; Gibson, D.; Brabec, V. Studies on Cellular Accumulation of Satraplatin and Its Major Metabolite JM118 and Their Interactions with Glutathione Mol. Pharmaceutics 2010, 7, 2093-2102
11. Hall, M. D.; Mellor, H. R.; Callaghan, R.; Hambley, T. W. Basis for Design and Development of Platinum(IV) Anticancer Complexes J. Med. Chem. 2007, 50, 3403-3411 (Pubitemid 47195446)
12. Novakova, O.; Vrana, O.; Kiseleva, V. I.; Brabec, V. DNA Interactions of Antitumor Platinum(IV) Complexes Eur. J. Biochem. 1995, 228, 616-624
13. Hall, M. D.; Amjadi, S.; Zhang, M.; Beale, P. J.; Hambley, T. W. The Mechanism of Action of Platinum(IV) Complexes in Ovarian Cancer Cell Lines J. Inorg. Biochem. 2004, 98, 1614-1624 (Pubitemid 39349187)
14. Ang, W. H.; Khalaila, I.; Allardyce, C. S.; Juillerat-Jeanneret, L.; Dyson, P. J. Rational Design of Platinum(IV) Compounds to Overcome Glutathione- S -Transferase Mediated Drug Resistance J. Am. Chem. Soc. 2005, 127, 1382-1383 (Pubitemid 40204507)
15. Barnes, K. R.; Kutikov, A.; Lippard, S. J. Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes Chem. Biol. 2004, 11, 557-564 (Pubitemid 38511760)
16. Mackay, F. S.; Woods, J. A.; Heringova, P.; Kasparkova, J.; Pizarro, A. M.; Moggach, S. A.; Parsons, S.; Brabec, V.; Sadler, P. J. A Potent Cytotoxic Photoactivated Platinum Complex Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 20743-20748
17. Choi, S.; Filotto, C.; Bisanzo, M.; Delaney, S.; Lagasee, D.; Whitworth, J. L.; Jusko, A.; Li, C.; Wood, N. A.; Willingham, J.; Schwenker, A.; Spaulding, K. Reduction and Anticancer Activity of Platinum(IV) Complexes Inorg. Chem. 1998, 37, 2500-2504 (Pubitemid 128487903)
18. Battle, A. R.; Deacon, G. B.; Dolman, R. C.; Hambley, T. W. Electrochemistry, Protein Binding and Crystal Structures of Platinum(II) and Platinum(IV) Carboxylato Complexes Aust. J. Chem. 2002, 55, 699-704
19. Reithofer, M. R.; Bytzek, A. K.; Valiahdi, S. M.; Kowol, C. R.; Groessl, M.; Hartinger, C. G.; Jakupec, M. A.; Galanski, M.; Keppler, B. K. Tuning of Lipophilicity and Cytotoxic Potency by Structural Variation of Anticancer Platinum(IV) Complexes J. Inorg. Biochem. 2011, 105, 46-51
20. Wilson, J. J.; Lippard, S. J. Synthesis, Characterization, and Cytotoxicity of Platinum(IV) Carbamate Complexes Inorg. Chem. 2011, 50, 3103-3115
21. Ang, W. H.; Pilet, S.; Scopelliti, R.; Bussy, F.; Juillerat-Jeanneret, L.; Dyson, P. J. Synthesis and Characterization of Platinum(IV) Anticancer Drugs with Functionalized Aromatic Carboxylate Ligands: Influence of the Ligands on Drug Efficacies and Uptake J. Med. Chem. 2005, 48, 8060-8069 (Pubitemid 41798436)
22. Galanski, M.; Keppler, B. K. Carboxylation of Dihydroxoplatinum(IV) Complexes via a New Synthetic Pathway Inorg. Chem. 1996, 35, 1709-1711
23. Shi, Y.; Liu, S. A.; Kerwood, D. J.; Goodisman, J.; Dabrowiak, J. C. Pt(IV) Complexes as Prodrugs for Cisplatin J. Inorg. Biochem. 2012, 107, 6-14
24. Still, B. M.; Kumar, P. G. A.; Aldrich-Wright, J. R.; Price, W. S. 195Pt NMR-theory and Application Chem. Soc. Rev. 2007, 36, 665-686
25. Pregosin, P. S. Platinum-195 Nuclear Magnetic Resonance Coord. Chem. Rev. 1982, 44, 247-291
26. 2] by l -cysteine and l -methionine and its Crystal Structure Dalton Trans. 1999, 1209-1212
27. Hansch, C.; Fujita, T. p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure J. Am. Chem. Soc. 1964, 86, 1616-1626
28. Warnke, U.; Rappel, C.; Meier, H.; Kloft, C.; Galanski, M.; Hartinger, C. G.; Keppler, B. K.; Jaehde, U. Analysis of Platinum Adducts with DNA Nucleotides and Nucleosides by Capillary Electrophoresis Coupled to ESI-MS: Indications of Guanosine 5′-Monophosphate O6-N7 Chelation ChemBioChem 2004, 5, 1543-1549 (Pubitemid 39531667)
29. van der Veer, J. L.; Peters, A. R.; Reedijk, J. Reaction Products from Platinum(IV) Amine Compounds and 5′-GMP are Mainly bis(5′-GMP) Platinum(II) Amine Adducts J. Inorg. Biochem. 1986, 26, 137-142 (Pubitemid 16127068)
30. Kelland, L. R.; Murrer, B. A.; Abel, G.; Giandomenico, C. M.; Mistry, P.; Harrap, K. R. Ammine Amine Platinum(IV) Dicarboxylates-A Novel Class of Platinum Complex Exhibiting Selective Cytotoxicity to Intrinsically Cisplatin-Resistant Human Ovarian Carcinoma Cell Lines Cancer Res. 1992, 52, 822-828
31. Khokhar, A. R.; AlBaker, S.; Shamsuddin, S.; Siddik, Z. H. Chemical and Biological Studies on a Series of Novel (trans -(1 R, 2R)-, trans -(1 S,2 S)-, and cis -1,2-Diaminocyclohexane)platinum(IV) Carboxylate Complexes J. Med. Chem. 1997, 40, 112-116 (Pubitemid 27027272)
32. Ellis, L. T.; Er, H. M.; Hambley, T. W. The Influence of the Axial Ligands of a Series of Platinum(IV) Anticancer Complexes on Their Reduction to Platinum(II) and Reaction with DNA Aust. J. Chem. 1995, 48, 793-806
33. Varbanov, H.; Valiahdi, S. M.; Legin, A. A.; Jakupec, M. A.; Roller, A.; Galanski, M.; Keppler, B. K. Synthesis and Characterization of Novel Bis(carboxylato)dichloridobis(ethylamine)platinum(IV) Complexes with Higher Cytotoxicity Than Cisplatin Eur. J. Med. Chem. 2011, 46, 5456-5464
34. Giandomenico, C. M.; Abrams, M. J.; Murrer, B. A.; Vollano, J. F.; Rheinheimer, M. I.; Wyer, S. B.; Bossard, G. E.; Higgins, J. D. Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes-An Entree into Orally-Active Platinum(IV) Antitumor Agents Inorg. Chem. 1995, 34, 1015-1021
35. Pichler, V.; Valiahdi, S. M.; Jakupec, M. A.; Arion, V. B.; Galanski, M.; Keppler, B. K. Mono-Carboxylated Diaminedichloridoplatinum(IV) Complexes-Selective Synthesis, Characterization, and Cytotoxicity Dalton Trans. 2011, 40, 8187-8192
36. Kizu, R.; Nakanishi, T.; Hayakawa, K.; Matsuzawa, A.; Eriguchi, M.; Takeda, Y.; Akiyama, N.; Tashiro, T.; Kidani, Y. A New Orally Active Antitumor 1 R,2 R -Cyclohexanediamine-Platinum(IV) Complex: trans -(n -valerato)chloro(1 R,2 R -cyclohexanediamine)(oxalato)platinum(IV) Cancer Chemother. Pharmacol. 1999, 43, 97-105
37. Zhang, J. Z.; Wexselblatt, E.; Hambley, T. W.; Gibson, D. Pt(IV) Analogs of Oxaliplatin that Do Not Follow the Expected Correlation Between Electrochemical Reduction Potential and Rate of Reduction by Ascorbate Chem. Commun. 2012, 48, 847-849
38. oct from Structures Chem. Rev. 1993, 93, 1281-1306
39. Oldfield, S. P.; Hall, M. D.; Platts, J. A. Calculation of Lipophilicity of a Large, Diverse Dataset of Anticancer Platinum Complexes and the Relation to Cellular Uptake J. Med. Chem. 2007, 50, 5227-5237 (Pubitemid 47585720)
40. Platts, J. A.; Hibbs, D. E.; Hambley, T. W.; Hall, M. D. Calculation of the Hydrophobicity of Platinum Drugs J. Med. Chem. 2000, 44, 472-474 (Pubitemid 32113591)
41. Song, R.; Kim, K. M.; Sohn, Y. S. Lipophilicity vs Antitumor Activity of Carboxylatoplatinum(IV) Complexes Bull. Korean Chem. Soc. 2000, 21, 1000-1004
42. 2] by Aqueous Extracts of Cancer Cells J. Med. Chem. 2007, 50, 5554-5556 (Pubitemid 350106008)
43. 3)(Am)] Anticancer Prodrugs Chem. Commun. 2010, 46, 1842-1844
44. Todd, R. C.; Lippard, S. J. Inhibition of Transcription by Platinum Antitumor Compounds Metallomics 2009, 1, 280-291
45. Andrews, P. A.; Wung, W. E.; Howell, S. B. A High-Performance Liquid-Chromatographic Assay with Improved Selectivity for Cisplatin and Active Platinum(II) Complexes in Plasma Ultrafiltrate Anal. Biochem. 1984, 143, 46-56 (Pubitemid 15157537)
46. Li, J.; Yap, S. Q.; Chin, C. F.; Tian, Q.; Yoong, S. L.; Pastorin, G.; Ang, W. H. Platinum(IV) Prodrugs Entrapped Within Multiwalled Carbon Nanotubes: Selective Release by Chemical Reduction and Hydrophobicity Reversal Chem. Sci. 2012, 3, 2083-2087
47. Ishida, S.; Lee, J.; Thiele, D. J.; Herskowitz, I. Uptake of the Anticancer Drug Cisplatin Mediated by the Copper Transporter Ctr1 in Yeast and Mammals Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 14298-14302 (Pubitemid 35257666)
48. Jones, N. A.; Turner, J.; McIlwrath, A. J.; Brown, R.; Dive, C. Cisplatin- and Paclitaxel-Induced Apoptosis of Ovarian Carcinoma Cells and the Relationship between Bax and Bak Up-Regulation and the Functional Status of p53 Mol. Pharmacol. 1998, 53, 819-826 (Pubitemid 28244068)
49. Hollstein, M.; Sidransky, D.; Vogelstein, B.; Harris, C. C. p53 Mutations in Human Cancers Science 1991, 253, 49-53 (Pubitemid 21917115)
50. Sablina, A. A.; Budanov, A. V.; Ilyinskaya, G. V.; Agapova, L. S.; Kravchenko, J. E.; Chumakov, P. M. The Antioxidant Function of the p53 Tumor Suppressor Nature Med. 2005, 11, 1306-1313 (Pubitemid 41752911)
51. Perez, J. M.; Camazón, M.; Alvarez-Valdes, A.; Quiroga, A. G.; Kelland, L. R.; Alonso, C.; Navarro-Ranninger, M. C. Synthesis, Characterization and DNA Modification Induced by a Novel Pt(IV)-bis(monoglutarate) Complex which Induces Apoptosis in Glioma Cells Chem.-Biol. Interact. 1999, 117, 99-115 (Pubitemid 29074298)
52. 2] Indian J. Chem. 1970, 8, 193-194
53. SMART, version 5.628; Bruker AXS Inc.: Madison, WI, 2001.
54. SAINT+, version 6.22a; Bruker AXS Inc.: Madison, WI, 2001.
55. Sheldrick, G. W. SADABS, version 2.10; University of Gottingen: Gottingen, Germany, 2001.
56. SHELXTL, version 6.14; Bruker AXS Inc.: Madison, WI, 2000.
57. Test No. 107: Partition Coefficient (n-octanol/water): Shake Flask Method; OECD Publishing: Paris, 1995.
58. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a Tetrazolium-Based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing Cancer Res. 1987, 47, 936-942 (Pubitemid 17027905)
59. Brummelkamp, T. R.; Bernards, R.; Agami, R. A System for Stable Expression of Short Interfering RNAs in Mammalian Cells Science 2002, 296, 550-553 (Pubitemid 34408678)